Average Co-Inventor Count = 8.98
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neotract, Inc. (24 from 68 patents)
2. Teleflex Life Sciences Pte. Ltd. (3 from 114 patents)
27 patents:
1. 12440301 - System for delivery of a fiducial marker
2. 12201283 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
3. 11471148 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
4. 11090036 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
5. 10945719 - Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
6. 10299780 - Apparatus and method for manipulating or retracting tissue and anatomical structure
7. 10143461 - Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
8. 10105132 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
9. 8940001 - Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
10. 8936609 - Apparatus and method for manipulating or retracting tissue and anatomical structure
11. 8900252 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
12. 8734468 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
13. 8715298 - Apparatus and method for manipulating or retracting tissue and anatomical structure
14. 8715239 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
15. 8663243 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions